S300 | Designates Xylazine as a schedule III depressant controlled substance | Smith & MosesS300Senate
Official Title
Designates Xylazine as a schedule III depressant controlled substance
2017-2018 SessionTerrence P. MurphyAffects: Public Health Law Status
In Senate Committee
Health
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate